Counseling about medication-induced birth defects with clinical decision support in primary care

Eleanor Schwarz, Sara M. Parisi, Steven M. Handler, Gideon Koren, Grant Shevchik, Gary S. Fischer

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: We evaluated how computerized clinical decision support (CDS) affects the counseling women receive when primary care physicians (PCPs) prescribe potential teratogens and how this counseling affects women's behavior. Methods: Between October 2008 and April 2010, all women aged 18-50 years visiting one of three community-based family practice clinics or an academic general internal medicine clinic were invited to complete a survey 5-30 days after their clinic visit. Women who received prescriptions were asked if they were counseled about teratogenic risks or contraception and if they used contraception at last intercourse. Results: Eight hundred one women completed surveys; 27% received a prescription for a potential teratogen. With or without CDS, women prescribed potential teratogens were more likely than women prescribed safer medications to report counseling about teratogenic risks. However, even with CDS 43% of women prescribed potential teratogens reported no counseling. In multivariable models, women were more likely to report counseling if they saw a female PCP (odds ratio: 1.97; 95% confidence interval: 1.26-3.09). Women were least likely to report counseling if they received angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Women who were pregnant or trying to conceive were not more likely to report counseling. Nonetheless, women who received counseling about contraception or teratogenic risks were more likely to use contraception after being prescribed potential teratogens than women who received no counseling. Conclusions: Physician counseling can reduce risk of medication-induced birth defects. However, efforts are needed to ensure that PCPs consistently inform women of teratogenic risks and provide access to highly effective contraception.

Original languageEnglish (US)
Pages (from-to)817-824
Number of pages8
JournalJournal of Women's Health
Volume22
Issue number10
DOIs
StatePublished - Oct 1 2013
Externally publishedYes

Fingerprint

Clinical Decision Support Systems
Counseling
Primary Health Care
Teratogens
Contraception
Primary Care Physicians
Prescriptions
Family Practice
Angiotensin Receptor Antagonists
Ambulatory Care
Internal Medicine

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Counseling about medication-induced birth defects with clinical decision support in primary care. / Schwarz, Eleanor; Parisi, Sara M.; Handler, Steven M.; Koren, Gideon; Shevchik, Grant; Fischer, Gary S.

In: Journal of Women's Health, Vol. 22, No. 10, 01.10.2013, p. 817-824.

Research output: Contribution to journalArticle

Schwarz, Eleanor ; Parisi, Sara M. ; Handler, Steven M. ; Koren, Gideon ; Shevchik, Grant ; Fischer, Gary S. / Counseling about medication-induced birth defects with clinical decision support in primary care. In: Journal of Women's Health. 2013 ; Vol. 22, No. 10. pp. 817-824.
@article{c63552d002c1459980edf6d6a29f8cf2,
title = "Counseling about medication-induced birth defects with clinical decision support in primary care",
abstract = "Background: We evaluated how computerized clinical decision support (CDS) affects the counseling women receive when primary care physicians (PCPs) prescribe potential teratogens and how this counseling affects women's behavior. Methods: Between October 2008 and April 2010, all women aged 18-50 years visiting one of three community-based family practice clinics or an academic general internal medicine clinic were invited to complete a survey 5-30 days after their clinic visit. Women who received prescriptions were asked if they were counseled about teratogenic risks or contraception and if they used contraception at last intercourse. Results: Eight hundred one women completed surveys; 27{\%} received a prescription for a potential teratogen. With or without CDS, women prescribed potential teratogens were more likely than women prescribed safer medications to report counseling about teratogenic risks. However, even with CDS 43{\%} of women prescribed potential teratogens reported no counseling. In multivariable models, women were more likely to report counseling if they saw a female PCP (odds ratio: 1.97; 95{\%} confidence interval: 1.26-3.09). Women were least likely to report counseling if they received angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Women who were pregnant or trying to conceive were not more likely to report counseling. Nonetheless, women who received counseling about contraception or teratogenic risks were more likely to use contraception after being prescribed potential teratogens than women who received no counseling. Conclusions: Physician counseling can reduce risk of medication-induced birth defects. However, efforts are needed to ensure that PCPs consistently inform women of teratogenic risks and provide access to highly effective contraception.",
author = "Eleanor Schwarz and Parisi, {Sara M.} and Handler, {Steven M.} and Gideon Koren and Grant Shevchik and Fischer, {Gary S.}",
year = "2013",
month = "10",
day = "1",
doi = "10.1089/jwh.2013.4262",
language = "English (US)",
volume = "22",
pages = "817--824",
journal = "Journal of Women's Health",
issn = "1540-9996",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - Counseling about medication-induced birth defects with clinical decision support in primary care

AU - Schwarz, Eleanor

AU - Parisi, Sara M.

AU - Handler, Steven M.

AU - Koren, Gideon

AU - Shevchik, Grant

AU - Fischer, Gary S.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Background: We evaluated how computerized clinical decision support (CDS) affects the counseling women receive when primary care physicians (PCPs) prescribe potential teratogens and how this counseling affects women's behavior. Methods: Between October 2008 and April 2010, all women aged 18-50 years visiting one of three community-based family practice clinics or an academic general internal medicine clinic were invited to complete a survey 5-30 days after their clinic visit. Women who received prescriptions were asked if they were counseled about teratogenic risks or contraception and if they used contraception at last intercourse. Results: Eight hundred one women completed surveys; 27% received a prescription for a potential teratogen. With or without CDS, women prescribed potential teratogens were more likely than women prescribed safer medications to report counseling about teratogenic risks. However, even with CDS 43% of women prescribed potential teratogens reported no counseling. In multivariable models, women were more likely to report counseling if they saw a female PCP (odds ratio: 1.97; 95% confidence interval: 1.26-3.09). Women were least likely to report counseling if they received angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Women who were pregnant or trying to conceive were not more likely to report counseling. Nonetheless, women who received counseling about contraception or teratogenic risks were more likely to use contraception after being prescribed potential teratogens than women who received no counseling. Conclusions: Physician counseling can reduce risk of medication-induced birth defects. However, efforts are needed to ensure that PCPs consistently inform women of teratogenic risks and provide access to highly effective contraception.

AB - Background: We evaluated how computerized clinical decision support (CDS) affects the counseling women receive when primary care physicians (PCPs) prescribe potential teratogens and how this counseling affects women's behavior. Methods: Between October 2008 and April 2010, all women aged 18-50 years visiting one of three community-based family practice clinics or an academic general internal medicine clinic were invited to complete a survey 5-30 days after their clinic visit. Women who received prescriptions were asked if they were counseled about teratogenic risks or contraception and if they used contraception at last intercourse. Results: Eight hundred one women completed surveys; 27% received a prescription for a potential teratogen. With or without CDS, women prescribed potential teratogens were more likely than women prescribed safer medications to report counseling about teratogenic risks. However, even with CDS 43% of women prescribed potential teratogens reported no counseling. In multivariable models, women were more likely to report counseling if they saw a female PCP (odds ratio: 1.97; 95% confidence interval: 1.26-3.09). Women were least likely to report counseling if they received angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Women who were pregnant or trying to conceive were not more likely to report counseling. Nonetheless, women who received counseling about contraception or teratogenic risks were more likely to use contraception after being prescribed potential teratogens than women who received no counseling. Conclusions: Physician counseling can reduce risk of medication-induced birth defects. However, efforts are needed to ensure that PCPs consistently inform women of teratogenic risks and provide access to highly effective contraception.

UR - http://www.scopus.com/inward/record.url?scp=84885034529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885034529&partnerID=8YFLogxK

U2 - 10.1089/jwh.2013.4262

DO - 10.1089/jwh.2013.4262

M3 - Article

VL - 22

SP - 817

EP - 824

JO - Journal of Women's Health

JF - Journal of Women's Health

SN - 1540-9996

IS - 10

ER -